immunotherapy

February 21, 2017 · Lindsay Dudbridge, ASCO staff
At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer. Read More >>
February 13, 2017 · Monika Sharda, ASCO staff
In this podcast, Dr. Sumanta Pal gives an overview of research that will be shared at the 2017 Genitourinary Cancers Symposium. Read More >>
2017 Clinical Cancer Advances
February 1, 2017 · Greg Guthrie, ASCO staff
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively. Read More >>
November 8, 2016 · Jyoti Patel, MD, FASCO
Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month. Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 5, 2016 · Greg Guthrie, ASCO staff
These studies from the ASCO Annual Meeting show some of the newest thoughts and latest advances in using immunotherapy and targeted therapy to treat bladder, stomach, and lung cancers. Read More >>

Pages